• Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 16 Mar 2025 01:16:17   America/Chicago


    Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 16, 2025 Share Link copied to clipboard. Remove Ads Sangamo Therapeutics, Inc.
    Read more...
Share on,